SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-18-000086
Filing Date
2018-08-07
Accepted
2018-08-07 16:09:25
Documents
61
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2018q210q.htm 10-Q 1083879
2 EXHIBIT 10.1 exh101.htm EX-10.1 52416
3 EXHIBIT 10.2 exh102.htm EX-10.2 13159
4 EXHIBIT 10.3 exh103.htm EX-10.3 101459
5 EXHIBIT 31.1 exh3112018q2.htm EX-31.1 13206
6 EXHIBIT 31.2 exh3122018q2.htm EX-31.2 13498
7 EXHIBIT 32 exh3212018q2.htm EX-32 11619
  Complete submission text file 0001358403-18-000086.txt   4806380

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT blcm-20180630.xml EX-101.INS 866530
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20180630.xsd EX-101.SCH 32519
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20180630_cal.xml EX-101.CAL 59571
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20180630_def.xml EX-101.DEF 155194
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20180630_lab.xml EX-101.LAB 470373
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20180630_pre.xml EX-101.PRE 271498
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 18998042
SIC: 2834 Pharmaceutical Preparations